Breaking News Instant updates and real-time market news.

CDMO

Avid Bioservices

$4.46

-0.19 (-4.09%)

, IGT

International Game

$24.39

-0.5 (-2.01%)

19:06
07/16/18
07/16
19:06
07/16/18
19:06

On The Fly: After Hours Movers

UP AFTER EARNINGS: Avid Bioservices (CDMO) up 3.8%. ALSO HIGHER: International Game Technology (IGT) up 4.3% after announcing FanDuel sports betting partnership... B&G Foods (BGS) up 2.7% after acquiring McCann Irish Oatmeal... First Majestic Silver (AG) up 1.2% after reporting Q2 production and raising output guidance. DOWN AFTER EARNINGS: Netflix (NFLX) down 14.2%, Roku (ROKU) down 2.6% in sympathy. ALSO LOWER: ABEO Pharma (AVEO) down 18.6% after pushing back Phase 3 data on Tiovo-3... Evolus (EOLS) down 10.9% after equity offering... Turquoise Hill (TRQ) down 7.8% after reporting Q2 production... Carbonite (CARB) down 6.3% after equity offering... Redfin (RDFN) down 4.5% after equity offering... Naked Brand Group (NAKD) down 4.5% after equity offering... Manitowoc (MTW) down 1.8% after Goldman Sachs downgrade... Amazon.com (AMZN) down 1.1% after technical glitches were reported on Prime Day.

CDMO

Avid Bioservices

$4.46

-0.19 (-4.09%)

IGT

International Game

$24.39

-0.5 (-2.01%)

BGS

B&G Foods

$29.80

-0.2 (-0.67%)

AG

First Majestic

$7.44

-0.265 (-3.44%)

NFLX

Netflix

$400.24

4.32 (1.09%)

ROKU

Roku

$48.27

-0.52 (-1.07%)

AVEO

Aveo Pharmaceuticals

$2.85

-0.055 (-1.90%)

EOLS

Evolus

$25.08

-1.12 (-4.27%)

TRQ

Turquoise Hill

$2.94

0.11 (3.89%)

CARB

Carbonite

$38.40

-0.1 (-0.26%)

RDFN

Redfin

$23.99

0.46 (1.96%)

NAKD

Naked Brand Group

$4.95

-0.15 (-2.94%)

MTW

Manitowoc

$26.99

-0.52 (-1.89%)

AMZN

Amazon.com

$1,822.02

9.02 (0.50%)

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 17

    Jul

  • 18

    Jul

  • 26

    Jul

  • 02

    Aug

  • 02

    Aug

  • 16

    Aug

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

CDMO Avid Bioservices
$4.46

-0.19 (-4.09%)

06/25/18
JANY
06/25/18
INITIATION
Target $10
JANY
Buy
Avid Bioservices initiated with a Buy at Janney Montgomery Scott
Janney Montgomery Scott analyst Paul Knight started Avid Bioservices with a Buy rating and $10 fair value estimate.
03/15/18
03/15/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Radian Group (RDN) initiated with a Neutral at Macquarie. 2. Cheniere Energy (LNG) initiated with a Buy at BofA/Merrill. 3. Avid Bioservices (CDMO) initiated with an Outperform at Wells Fargo. 4. Quintana Energy Services (QES) initiated with an Overweight at Capital One. 5. II-VI (IIVI) initiated with a Buy at DA Davidson. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/24/18
HCWC
05/24/18
INITIATION
Target $5
HCWC
Buy
Avid Bioservices initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis started Avid Bioservices with a Buy rating and $5 price target. The shares offer an opportunity to invest in a "well established, publicly traded, contract development and manufacturing company," Pantginis tells investors in a research note. Avid provides investors an opportunity to benefit in Avid's revenue upside, as most contract manufacturing organizations are privately held, the analyst adds.
04/09/18
FANA
04/09/18
NO CHANGE
Target $4
FANA
Overweight
Avid Bioservices a 'compelling' opportunity for investors, says First Analysis
First Analysis analyst Steven Schwartz reiterated an Overweight rating on Avid Biosciences following an in-depth discussion with CEO Roger Lias, which provided additional insights and an update on progress since their January meeting. In a research note to investors, Schwartz, who has a $4 price target on the stock, says that though Avid will likely see minimal revenue growth in the next two years, it is a "compelling" opportunity for investors with a longer-term investment horizon to start evaluating and building a position at attractive valuations.
IGT International Game
$24.39

-0.5 (-2.01%)

05/23/18
DBAB
05/23/18
NO CHANGE
Target $35
DBAB
Buy
Deutsche Bank recommends buying shares of International Game
If not for the forward transaction entered into by International Game Technology's controlling shareholder, the shares would have responded "very well" yesterday to the fundamentals and the outlook presented in IGT's Q1 and on the conference call, Deutsche Bank analyst Carlo Santarelli tells investors in a research note. He believes International Game "represents a strong operating story at a healthy discount to peers, with several avenues for accelerating growth." The analyst recommends buying the stock and keeps a Buy rating on the name with a $35 price target.
05/15/18
BOFA
05/15/18
NO CHANGE
BOFA
Supreme Court ruling on sports betting positive for regionals, game tech, says BofA/Merrill
BofA/Merrill analyst Shaun Kelley notes that the Supreme Court ruled 6-3 to repeal the Professional and Amateur Sports Protection Act, which had effectively banned full sports betting in every state except Nevada. While the analyst expects operator margins to be low, he sees upside for all of regional gaming, while gaming tech could be a key beneficiary. Reflecting sports betting in higher multiples, Kelley raised his price targets for Boyd Gaming (BYD) to $45 from $42, Penn National (PENN) to $36 from $32, Scientific Games (SGMS) to $70 from $60, and International Game (IGT) to $36 from $34.
06/15/18
UGAM
06/15/18
UPGRADE
UGAM
Buy
International Game upgraded to Buy from Hold at Union Gaming
06/15/18
06/15/18
UPGRADE
Target $33

Buy
International Game upgraded to Buy on valuation at Union Gaming
As previously reported, Union Gaming upgraded International Game to Buy from Hold. Analyst John DeCree changed his view saying valuation is attractive ahead of the August 2 analyst day.
BGS B&G Foods
$29.80

-0.2 (-0.67%)

06/19/18
PIPR
06/19/18
INITIATION
Target $31
PIPR
Neutral
B&G Foods assumed with a Neutral at Piper Jaffray
Piper Jaffray analyst Michael Lavery assumed coverage of B&G Foods with a Neutral rating and $31 price target. The company's low share positions come with risk of potential distribution losses, Lavery tells investors in a research note. He expects "moderate" earnings growth of 2%-3% over the next few years.
03/07/18
03/07/18
DOWNGRADE
Target $21

Underperform
B&G Foods downgraded to Underperform at Credit Suisse
As previously reported, Credit Suisse analyst Robert Moskow downgraded B&G Foods to Underperform from Neutral saying that despite management lowering its EBITDA outlook for 2018 well below consensus, he expects another year of negative revisions ahead, similar to 2017. The analyst also lowered his price target on the shares to $21 from $34.
05/04/18
BREN
05/04/18
UPGRADE
BREN
Buy
B&G Foods upgraded to Buy from Hold at Berenberg
06/19/18
06/19/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Ollie's Bargain Outlet (OLLI) initiated with a Hold at Loop Capital. 2. B&G Foods (BGS) assumed with a Neutral at Piper Jaffray. 3. Iterum Therapeutics (ITRM) initiated with an Outperform at RBC Capital and Leerink while being initiated with a Buy at Needham and Guggenheim. 4. Ingersoll-Rand (IR) initiated with an Outperform at Cowen. 5. Ally Financial (ALLY) initiated with a Neutral at Nomura Instinet. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
AG First Majestic
$7.44

-0.265 (-3.44%)

05/14/18
BMOC
05/14/18
UPGRADE
Target $9
BMOC
Market Perform
First Majestic upgraded to Market Perform from Underperform at BMO Capital
05/14/18
BMOC
05/14/18
UPGRADE
Target $9
BMOC
Market Perform
First Majestic upgraded to Market Perform at BMO Capital on San Dimas deal
As noted earlier, BMO Capital analyst Ryan Thompson upgraded First Majestic to Market Perform from Underperform and raised his price target to CAD 9 from CAD 7.50. The analyst says the San Dimas mine agreement announced last week supports his investment thesis through "accretive cash flow and net present value metrics", but adds that the stock looks fully priced at current levels. Thomson still recommends that investors consider First Majestic for exposure to "above-average leverage to a rising silver price."
05/15/18
TDSI
05/15/18
UPGRADE
TDSI
Buy
First Majestic upgraded to Buy from Hold at TD Securities
04/25/18
ROTH
04/25/18
INITIATION
Target $9
ROTH
Buy
First Majestic initiated with a Buy at Roth Capital
Roth Capital analyst Jake Sekelsky started First Majestic with a Buy rating and $9 price target as he views it as one of the few silver pure plays with a goal of significantly increasing production over the next year.
NFLX Netflix
$400.24

4.32 (1.09%)

07/16/18
RBCM
07/16/18
NO CHANGE
Target $360
RBCM
Outperform
Netflix consensus 'reasonable' ahead of today's Q2, says RBC Capital
RBC Capital analyst Mark Mahaney says the Street consensus for Netflix earnings, revenue, and subscriber additions is "reasonable" ahead of today's Q2 earnings based on his "intra-quarter data points, proprietary quarterly survey work, and model sensitivity" analysis. The analyst keeps his Outperform rating and $360 price target, stating that Netflix "achieved a level of sustainable scale, growth, and profitability that isn't currently reflected in its stock price". Mahaney also cautions however than the downside risk on Netflix may be greater than usual this time because of adverse FX fluctuations in Q2.
07/16/18
07/16/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. NETFLIX CUT TO UNDERPERFORM AT BUCKINGHAM: Buckingham analyst Matthew Harrigan downgraded Netflix (NFLX) to Underperform from Neutral ahead of the company's earnings report, as he estimates that the stock's current price implies "optimistic" views of the company reaching 360M global members in 2025 and 505M by 2033 along with a long-term operating profit margin near 35%. UBS NOW FAVORS UPS OVER FEDEX: UBS analyst Thomas Wadewitz upgraded UPS (UPS) to Buy from Neutral and raised his price target for the shares to $125 from $121. The combination of cost and productivity improvements, coupled with a "constructive" revenue backdrop, provide potential for improved Domestic Package margin performance and stronger operating income growth in 2019 for UPS, Wadewitz told investors. The analyst believes the company has "multiple cost side drivers" and that the new Teamsters agreement may also facilitate growth. Wadewitz this morning also downgraded FedEx (FDX) to Neutral from Buy and lowered his price target for the shares to $256 from $283. With a large global Express business representing 55% of revenue and about 13% of revenue linked to Asia, FedEx is exposed to risk from tariffs and potentially slower trade activity, Wadewitz told investors. The analyst sees limited visibility to near term margin expansion as the company is still ramping up integration with TNT in Europe. In midday trading, UPS is up just over 1%, while FedEx is down 1.5%. BMO CUTS HASBRO TO UNDERPERFORM: BMO Capital analyst Gerrick Johnson downgraded Hasbro to Underperform from Market Perform and lowered his price target to $75 from $80. The analyst noted that the liquidation of Toys R US may be "more impactful than investors realize" after the initial 9% rally in the stock price on "relief that things were not worse", even as retailers are becoming more selective in the "pantry loading" inventory restocking process. JPMORGAN SEES LOW THREAT FROM AMAZON TO NETWORK EQUIPMENT STOCKS: JPMorgan analyst Samik Chatterjee told investors in a research note that he believes the threat of Amazon (AMZN) entering into the networking equipment market is "relatively low" for networking equipment stocks including Arista Networks (ANET), Cisco Systems (CSCO), and Juniper Networks (JNPR), contending that AWS' switching product will target data center capital spending from large enterprise customers, which is only a $2.5B opportunity relative to the $12B data center switching and $16B campus switching market.
07/16/18
07/16/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Aptinyx (APTX) initiated with an Overweight at JPMorgan and an Outperform at BMO Capital as well as Aptinyx (APTX). 2. Magenta Therapeutics (MGTA) initiated with an Outperform at Wedbush, an Outperform at Cowen and JPMorgan, as well as a Buy at Goldman Sachs. 3. Wyndham Destinations (WYND) and Marriott Vacations (VAC) were initiated with a Buy at Jefferies while Hilton Grand Vacations (HGV) was initiated with a Hold. 4. AvroBio (AVRO) initiated with an Outperform at Wedbush, Cowen, and Wells Fargo, and an Overweight at Morgan Stanley. 5. Keurig Dr Pepper (KDP) resumed with a Buy at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/16/18
07/16/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Netflix (NFLX) downgraded to Underperform from Neutral at Buckingham with analyst Matthew Harrigan saying he estimates that the stock's current price implies "optimistic" views of the company reaching 360M global members in 2025 and 505M by 2033 along with a long-term operating profit margin near 35%. 2. Rockwell Automation (ROK) downgraded to Sell from Neutral at Goldman Sachs while Parker-Hannifin (PH) was downgraded to Neutral from Buy. 3. FedEx (FDX) downgraded to Neutral from Buy at UBS with analyst Thomas Wadewitz saying with a large global Express business representing 55% of revenue and about 13% of revenue linked to Asia, FedEx is exposed to risk from tariffs and potentially slower trade activity. 4. Hasbro (HAS) downgraded to Underperform from Market Perform at BMO Capital with analyst Gerrick Johnson saying the liquidation of Toys R US may be "more impactful than investors realize" after the initial 9% rally in the stock price on "relief that things were not worse," even as retailers are becoming more selective in the "pantry loading" inventory restocking process. 5. Intrexon (XON) downgraded to Underperform from Neutral at BofA/Merrill with analyst Derik de Bruin citing lack of near-term catalysts and lack of contribution from "advanced" programs until 2020s. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
ROKU Roku
$48.27

-0.52 (-1.07%)

06/14/18
06/14/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Spotify (SPOT) initiated with a Hold at Deutsche Bank. 2. Hannon Armstrong (HASI) initiated with an Overweight at JPMorgan. 3. Wyndham Hotels & Resorts (WH) and Wyndham Destinations (WYND) were initiated with a Buy at SunTrust. 4. RigNet (RNET) initiated with a Buy at Maxim. 5. Roku (ROKU) initiated with an Outperform at Macquarie. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, Reference Link
07/03/18
OPCO
07/03/18
UPGRADE
OPCO
Outperform
Roku upgraded to Outperform from Perform at Oppenheimer
07/03/18
07/03/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Albemarle (ALB) upgraded to Buy from Neutral at Goldman Sachs with analyst Robert Koort saying the selloff in companies tied to lithium is overdone. 2. Veon (VEON) upgraded to Overweight from Neutral at JPMorgan with analyst Alexei Gogolev stating that the company shed its Italian business at a "very attractive price". 3. Roku (ROKU) upgraded to Outperform from Perform at Oppenheimer with analyst Jason Helfstein saying the "rapid adoption" of The Roku Channel gives him incremental confidence in the channel's ability to garner viewership on other platforms. 4. Amedisys (AMED) upgraded to Buy from Neutral at BofA/Merrill with analyst Joanna Gajuk stating that last night's CMS proposal increased reimbursement visibility for the home health industry calling for a +2.1% rate update in 2019, the best update since 2007 following nine consecutive years of cuts. 5. NetEase (NTES) upgraded to Overweight from Underweight at JPMorgan with analyst Alex Yao saying he expects NetEase to end a six-quarter "earnings downgrade cycle" with its "lackluster" earnings growth starting to recover in Q2 and peaking in Q1 of 2019. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/03/18
OPCO
07/03/18
UPGRADE
Target $50
OPCO
Outperform
Oppenheimer upgrades Roku to Outperform on 'rapid' channel adoption
Oppenheimer analyst Jason Helfstein upgraded Roku to Outperform from Perform and established a $50 price target for the shares. The manufacturer of streaming players closed yesterday up 67c to $43.29. The Roku Channel is 0.63% of domestic time-spent on Roku's platform or the 12th most-watched app by viewing hours, which represents a 9M hour monthly run-rate only nine months post-launch, Helfstein tells investors in a research note titled. The analyst says the "rapid adoption" of The Roku Channel gives him incremental confidence in the channel's ability to garner viewership on other platforms, such as Samsung (SSNLF). This should allow Roku to monetize a broader portion of the over-the-top ecosystem, Helfstein contends. He values the core platform at $44 per share and the off-platform Roku Channel opportunity at $7 per share, which, when combined, represents 18% upside from current share levels.
AVEO Aveo Pharmaceuticals
$2.85

-0.055 (-1.90%)

11/13/17
11/13/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Party City (PRTY) assumed with an Overweight at JPMorgan. 2. MongoDB (MDB) was initiated with a Buy at Stifel and Canaccord, an Overweight at Barclays, an Equal Weight at Morgan Stanley, a Market Perform at JMP Securities, and a Neutral at Goldman Sachs. 3. Arista Networks (ANET) initiated with a Neutral at Piper Jaffray. 4. NetScout (NTCT) initiated with an Overweight at Piper Jaffray. 5. Aveo Oncology (AVEO) initiated with a Buy at B. Riley FBR. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/06/17
GHSC
10/06/17
INITIATION
Target $7
GHSC
Buy
AVEO Oncology initiated with a Buy at Seaport Global
Seaport Global analyst Vernon Bernardino initiated AVEO Oncology with a Buy and $7 price target.
03/29/18
PIPR
03/29/18
NO CHANGE
Target $5
PIPR
Overweight
Aveo Oncology should be bought ahead of Phase III data, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff expects Aveo Oncology to report Phase III Tivo-3 data in third-line renal cell carcinoma in Q2. The analyst is confident tivozanib will achieve a statistically significant survival benefit over Nexavar and recommeds buying the stock ahead of the readout. Positive data will enable Aveo to respond to the 2013 tivozanib complete response letter with potential FDA approval in 2019, Tenthoff tells investors in a research note. He reiterates an Overweight rating on the shares with a $5 price target.
11/13/17
RILY
11/13/17
INITIATION
Target $5
RILY
Buy
Aveo Oncology initiated with a Buy at B. Riley FBR
B. Riley FBR analyst Madhu Kumar started Aveo Oncology with a Buy rating and $5 price target. The analyst sees the company's lead asset, vascular endothelial growth factor receptor tyrosine kinase inhibitor Fotivda, being successful in the pivotal Tivo-3 trial reading out in Q1 of 2018. He views the drug as undervalued.
EOLS Evolus
$25.08

-1.12 (-4.27%)

05/16/18
WELS
05/16/18
NO CHANGE
WELS
Outperform
Evolus CRL good news for Allergan, says Wells Fargo
Wells Fargo analyst David Maris noted that Evolus (EOLS) received a Complete Response Letter for its application for cosmetic neuro toxin candidate DWP-450, which he views as good news for Allergan (AGN) as the delay means Evolus will miss the 2018-2019 holiday season, which he points out is an important selling season for Botox. Maris, who also thinks Allergan may be able to use the CRL to "counter-detail" DWP-450 with doctors if the product does reach market, keeps an Outperform rating on Allergan shares.
05/29/18
JMPS
05/29/18
NO CHANGE
Target $30
JMPS
Outperform
Evolus price target raised to $30 after executive hirings at JMP Securities
After Evolus (EOLS) announced that it hired Lauren Silvernail, formerly the CFO at Revance Therapeutics (RVNC), to be its own CFO, JMP Securities analyst Donald Ellis noted this was the second hiring by the company of a C-suite executive from a major competitor after the company had previously hired CEO David Moatazedi from Allergan (AGN). The analyst, who contends that both Moatazedi and Silvernail "have voted with their feet for the winner in the aesthetic toxin market," increased his view of the probability of approval for DWP-450 to 100% from 80%, which drove up his price target on Evolus shares to $30 from $22. Ellis maintains his Outperform rating on Evolus.
06/13/18
CANT
06/13/18
NO CHANGE
Target $35
CANT
Overweight
Evolus price target raised to $35 from $25 at Cantor Fitzgerald
Cantor Fitzgerald analyst Louise Chen raised her price target for Evolus to $35 citing improved visibility for the peak sales potential of DWP-450. Although Evolus is not providing the details of its Complete Response Letter, the company said that over half of the questions listed in the CRL have been resolved, Chen tells investors in a research note. The analyst continues to see a "smooth" path to approval and keeps an Overweight rating on Evolus shares.
06/11/18
MZHO
06/11/18
NO CHANGE
Target $33
MZHO
Buy
Evolus price target raised to $33 from $16 at Mizuho
Mizuho analyst Irina Koffler raised her price target for Evolus to $33 citing lower risk and higher market growth expectations. The analyst reiterates a Buy rating on the shares.
TRQ Turquoise Hill
$2.94

0.11 (3.89%)

09/15/17
CIBC
09/15/17
INITIATION
CIBC
Outperformer
Turquoise Hill initiated with an Outperformer at CIBC
CARB Carbonite
$38.40

-0.1 (-0.26%)

11/27/17
JMPS
11/27/17
NO CHANGE
JMPS
Outperform
JMP Securities reiterates Outperform rating on Carbonite after Barracuda buyout
After Barracuda Networks (CUDA) announced a deal to be acquired by Thoma Bravo for $27.55 per share in cash, JMP Securities analyst Erik Suppiger reiterated his Outperform rating on Carbonite (CARB), saying that the deal validates the attraction of the small and midsize business data protection and security market. He also noted that Carbonite trades at a 33% discount to the deal price agreed to for Barracuda on a revenue multiple basis and a 34% discount on an earnings multiple basis based on 2018 estimates.
05/08/18
OPCO
05/08/18
NO CHANGE
Target $35
OPCO
Outperform
Carbonite price target raised to $35 from $30 at Oppenheimer
Oppenheimer analyst Brian Schwartz raised his price target for Carbonite to $35 from $30 as he believes the company's execution remains "solid" as the business yields "strong" margin improvements in Q1. The analyst reiterates an Outperform rating on the shares.
05/08/18
LSCM
05/08/18
NO CHANGE
Target $34
LSCM
Buy
Carbonite price target raised to $34 from $27 at Lake Street
Lake Street analyst Eric Martinuzzi raised his price target for Carbonite to $34 saying the company showed "solid execution across the board" in Q1. The analyst keeps a Buy rating on the shares.
05/08/18
CHLM
05/08/18
NO CHANGE
Target $40
CHLM
Buy
Carbonite price target raised to $40 from $30 at Craig-Hallum
Craig-Hallum analyst Chad Bennett raised his price target for Carbonite to $40 from $30 following a "good" quarter. The analyst reiterates a Buy rating on the shares.
RDFN Redfin
$23.99

0.46 (1.96%)

05/22/18
DADA
05/22/18
NO CHANGE
Target $28
DADA
Buy
Redfin listing market share gains are accelerating, says DA Davidson
DA Davidson analyst Tom White kept his Buy rating and $28 price target on Redfin, saying his tracking of for-sale residential home listings across 26 markets over the past 10.5 weeks suggests that the company's pace of market share gains is accelerating. Given the current 1.4K listings in 26 markets - about 0.7% of all listed homes in the area - White calculates that Redfin's listing share has increased by 0.005% per day since May 2nd, which is up from 0.04% acceleration in the prior 10 weeks. The analyst believes that Redfin's market share gains will likely remain impressive, though the low for-sale inventory could keep the pressure on the company's revenue and EBITDA upside.
06/18/18
GSCO
06/18/18
DOWNGRADE
Target $21
GSCO
Sell
Redfin downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Heath Terry downgraded Redfin (RDFN) to Sell with an unchanged price target of $21. Macro pressures have an outsized impact on Redfin, Terry tells investors in a research note. He downgraded the online real estate stocks ahead of what has historically been a period of seasonal underperformance, along with expectations for continued tightness in housing and mortgage availability as well as signs of increasing competition in the online real estate category. Terry this morning also downgraded Zillow Group (ZG) to Neutral.
06/18/18
06/18/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Redfin (RDFN) was downgraded to Sell from Neutral at Goldman Sachs while Zillow (Z, ZG) was downgraded to Neutral from Buy. 2. Dun & Bradstreet (DNB) downgraded to Neutral from Outperform at Baird with analyst Jeffrey Meuler saying he believes any potential take-out is already priced into the shares, the current valuation seems to limit potential upside, and the business requires more substantial changes to return it to sustainable organic growth. 3. Hibbett Sports (HIBB) downgraded to Underperform from Buy at BofA/Merrill analyst Rafe Jadrosich saying he expects negative same-store-sales declines in Q4 and continuing through 2020 as Hibbett laps the ecommerce launch and excess inventory clearance. 4. Cheesecake Factory (CAKE) downgraded to Neutral on valuation at BTIG with analyst Peter Saleh citing recent share strength. 5. Intel (INTC) downgraded to Underperform from Market Perform at Northland. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/25/18
ZELM
06/25/18
INITIATION
ZELM
Buy
Redfin initiated with a Buy at Zelman
NAKD Naked Brand Group
$4.95

-0.15 (-2.94%)

MTW Manitowoc
$26.99

-0.52 (-1.89%)

06/06/18
RHCO
06/06/18
UPGRADE
Target $33
RHCO
Buy
Manitowoc upgraded to Buy from Hold at SunTrust
SunTrust analyst Charles Brady upgraded Manitowoc to Buy from Hold and increased his price target to $33 from $36 after attending the company's Crane Day at the Shady Grove plant. In a research note to investors, Brady said he came away from Crane Day "incrementally more positive" on Manitowoc's outlook and said he was "impressed" with the company's increased pace of product development, greater platform parts commonality and breadth of new product introductions. Brady believes Manitowoc is at or near an inflection point for meaningful earnings accretion, and raised his 2018 and 2019 EPS estimates to 47c and $1.44 from 32c and $1.22, respectively, and established a 2020 EPS estimate of $2.11.
06/06/18
RHCO
06/06/18
UPGRADE
RHCO
Buy
Manitowoc upgraded to Buy from Hold at SunTrust
07/16/18
GSCO
07/16/18
DOWNGRADE
GSCO
Sell
Manitowoc downgraded to Sell from Neutral at Goldman Sachs
06/21/18
JPMS
06/21/18
UPGRADE
Target $25
JPMS
Neutral
Manitowoc upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst Ann Duignan upgraded Manitowoc to Neutral and raised her price target for the shares to $25 from $24. The analyst sees a more balanced risk/reward following the year-to-date underperformance of the shares.
AMZN Amazon.com
$1,822.02

9.02 (0.50%)

07/16/18
MSCO
07/16/18
NO CHANGE
MSCO
Overweight
Survey of CIOs signals strong momentum for Microsoft, says Morgan Stanley
Morgan Stanley analyst Keith Weiss said the firm's latest quarterly survey of Chief Information Officers points to continued strength in 2018 IT budget growth outlooks, with expectations of forward budget revisions growing even more positive. 34% of CIOs plan to upgrade to a higher subscription level of Office 365 in the next 12-24 months and Microsoft (MSFT) continues to be a top share gainer of IT budget as workloads shift to the cloud, noted Weiss. He also pointed out that Microsoft is the top vendor that CIOs expect to benefit from Digital Transformation initiatives, replacing Amazon (AMZN) in the same survey at this time last year. Weiss maintains an Overweight rating on Microsoft shares.
07/13/18
JPMS
07/13/18
NO CHANGE
JPMS
Amazon reported datacenter switching plans negative for Nokia, says JPMorgan
JPMorgan analyst Sandeep Deshpande said Amazon's (AMZN) reported potential foray into datacenter switching is a negative for Nokia's (NOK) efforts in the enterprise market. While it does not surprise him that AWS uses white-box switches in its datacenters, a move toward launching commercial products would be and he believes such a launch would have a negative read-across to Nokia, which recently launched its FP4-powered platform for core routing. If AWS enters, Nokia's product will need to be substantially differentiated for customers to choose it, added Deshpande.
07/16/18
LOOP
07/16/18
NO CHANGE
Target $1900
LOOP
Buy
Amazon.com Prime Day to be 'highly successful', says Loop Capital
Loop Capital analyst Anthony Chukumba kept his Buy rating and $1,900 price target on Amazon (AMZN), saying the company's Prime Day starting today will be "highly successful" in generating significant shopping volume, driving incremental new membership, and providing "valuable free advertising". The analyst further notes that Prime Day will contain 6 additional hours relative to last year and also integrate Whole Foods into its offerings, whereby "Prime Rewards Visa (V) card holders will receive 10% back - twice the usual level - on up to $400 of Whole Foods Market purchases July 14th-17th.

TODAY'S FREE FLY STORIES

TOL

Toll Brothers

$29.87

-1.96 (-6.16%)

15:45
11/15/18
11/15
15:45
11/15/18
15:45
Options
Toll Brothers call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

AAPL

Apple

$190.76

3.95 (2.11%)

15:44
11/15/18
11/15
15:44
11/15/18
15:44
Periodicals
Apple partners with A24 to make feature-length movies, Variety says »

Apple is enlisting indie…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$191.08

4.27 (2.29%)

15:42
11/15/18
11/15
15:42
11/15/18
15:42
Periodicals
Breaking Periodicals news story on Apple »

Apple and movie studio…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BTI

British American Tobacco

$34.97

-1.54 (-4.22%)

15:41
11/15/18
11/15
15:41
11/15/18
15:41
Hot Stocks
British American says menthol cigarettes should not be treated 'differently' »

In a statement regarding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:38
11/15/18
11/15
15:38
11/15/18
15:38
Hot Stocks
Breaking Hot Stocks news story  »

Greenpro Capital…

WTW

Weight Watchers

$49.93

0.91 (1.86%)

15:37
11/15/18
11/15
15:37
11/15/18
15:37
Conference/Events
Weight Watchers management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

WSM

Williams-Sonoma

$60.33

-1.43 (-2.32%)

15:34
11/15/18
11/15
15:34
11/15/18
15:34
Options
Williams Sonoma options imply 10.9% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

15:33
11/15/18
11/15
15:33
11/15/18
15:33
Hot Stocks
Breaking Hot Stocks news story  »

Greenpro Capital…

QLYS

Qualys

$74.55

2.63 (3.66%)

15:32
11/15/18
11/15
15:32
11/15/18
15:32
Conference/Events
Qualys management to meet with JPMorgan »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 20

    Nov

  • 09

    Jan

FAST

Fastenal

$57.06

1.21 (2.17%)

15:30
11/15/18
11/15
15:30
11/15/18
15:30
Options
Timely sweep of Fastenal calls »

Timely sweep of Fastenal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$272.54

2.35 (0.87%)

15:28
11/15/18
11/15
15:28
11/15/18
15:28
Hot Stocks
Assistant AG Delrahim says DOJ seeks to curtail bid-rigging in gov't purchases »

Assistant Attorney…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$272.54

2.35 (0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWK

Stanley Black & Decker

$129.03

4.03 (3.22%)

15:27
11/15/18
11/15
15:27
11/15/18
15:27
Conference/Events
Stanley Black & Decker management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

DDS

Dillard's

$63.35

-10.28 (-13.96%)

15:27
11/15/18
11/15
15:27
11/15/18
15:27
Downgrade
Dillard's rating change  »

Dillard's downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UHS

Universal Health

$127.24

-0.05 (-0.04%)

15:20
11/15/18
11/15
15:20
11/15/18
15:20
Options
Notable call spread in Universal Health as shares advance »

Notable call spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JWN

Nordstrom

$58.79

-2.305 (-3.77%)

15:19
11/15/18
11/15
15:19
11/15/18
15:19
Options
Nordstrom options imply 9.4% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

SPY

SPDR S&P 500 ETF Trust

$271.84

1.65 (0.61%)

, SPX

S&P 500

$0.00

(0.00%)

15:17
11/15/18
11/15
15:17
11/15/18
15:17
General news
U.S. official: China trade offer should be viewed with skepticism, Reuters says »

An unnamed U.S.…

SPY

SPDR S&P 500 ETF Trust

$271.84

1.65 (0.61%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
11/15/18
11/15
15:17
11/15/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
11/15/18
11/15
15:16
11/15/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMAT

Applied Materials

$35.42

1.83 (5.45%)

15:04
11/15/18
11/15
15:04
11/15/18
15:04
Options
Applied Materials options imply 6.6% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

RMNI

Rimini Street

$5.45

0.13 (2.44%)

15:04
11/15/18
11/15
15:04
11/15/18
15:04
Hot Stocks
Rimini Street expands investment and operations in Asia-Pacific »

Rimini Street announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$273.24

3.05 (1.13%)

, SPX

S&P 500

$0.00

(0.00%)

15:03
11/15/18
11/15
15:03
11/15/18
15:03
General news
Breaking General news story on SPDR S&P 500 ETF Trust, S&P 500 »

Ross says U.S. still…

SPY

SPDR S&P 500 ETF Trust

$273.24

3.05 (1.13%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATVI

Activision Blizzard

$53.35

1.74 (3.37%)

15:00
11/15/18
11/15
15:00
11/15/18
15:00
Options
Timely put write in ActivisionBlizzard »

Timely put write in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

14:55
11/15/18
11/15
14:55
11/15/18
14:55
General news
Trump Fed Board nominee Michelle Bowman was confirmed »

Trump Fed Board nominee…

14:55
11/15/18
11/15
14:55
11/15/18
14:55
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

MFSF

MutualFirst Financial

$35.64

0.64 (1.83%)

14:53
11/15/18
11/15
14:53
11/15/18
14:53
Hot Stocks
MutualFirst Financial increases dividend 11% »

MutualFirst Financial,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.